Skip to content

Nuvation Bio NUVB Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$145.99M+28.7%-$204.63M+5.9%-$217.48M-7.2%-$202.9M+66.5%-$606.38M-6.8%
$1.97M+13.0%$1.74M+22.6%$1.42M+35.5%$1.05M+12.0%$935K+36.9%
$37.07M+3.3%$35.89M-5.8%$38.1M+1.5%$37.55M+7.0%$35.09M+8.7%
-$125.73M+27.5%-$173.43M+8.7%-$190M-13.0%-$168.19M-6.9%-$157.34M-20.6%
$7.98M-0.3%$8M0.0%$8M+3,440%$226K+402%$45K
$189.95M+12.2%$169.34M+38.0%
$202.03M-0.2%$202.54M
-$133.71M+26.3%-$181.43M+8.4%-$198M-17.6%-$168.42M-7.0%-$157.38M-20.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Nuvation Bio's cash flow data come from?
Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.